Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Boehringer Ingelheim
Dow
Johnson and Johnson
Medtronic

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Uridine-5'-Diphosphate

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Uridine-5'-Diphosphate?

Uridine-5'-Diphosphate is an investigational drug.

There have been 31 clinical trials for Uridine-5'-Diphosphate. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2014.

The most common disease conditions in clinical trials are Depression, Bipolar Disorder, and HIV Infections. The leading clinical trial sponsors are National Cancer Institute (NCI), Repligen Corporation, and Mclean Hospital.

There are eleven US patents protecting this investigational drug and five hundred and eleven international patents.

Recent Clinical Trials for Uridine-5'-Diphosphate
TitleSponsorPhase
Clinical Utility of Pharmacogenomics of Psychotropic MedicationsOregon Health and Science UniversityPhase 4
Citicoline Concentration in Human VitreousFondazione G.B. Bietti, IRCCSN/A
Citicoline Concentration in Human VitreousIstituto di Ricerca Neuroftalmologia S.r.l.N/A

See all Uridine-5'-Diphosphate clinical trials

Clinical Trial Summary for Uridine-5'-Diphosphate

Top disease conditions for Uridine-5'-Diphosphate
Top clinical trial sponsors for Uridine-5'-Diphosphate

See all Uridine-5'-Diphosphate clinical trials

US Patents for Uridine-5'-Diphosphate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Uridine-5'-Diphosphate   Start Trial Compositions containing pufa and/or uridine and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGIES (Cambridge, MA)   Start Trial
Uridine-5'-Diphosphate   Start Trial Compositions containing PUFA and methods of use thereof MASSACHUSETS INSTITUE OF TECHNOLOGY (Cambridge, MA)   Start Trial
Uridine-5'-Diphosphate   Start Trial Process for purifying nucleoside-5'-diphosphates Du Pont Merck Pharmaceutical Company (Wilmington, DE)   Start Trial
Uridine-5'-Diphosphate   Start Trial Process for producing carbohydrates using .beta. 1,3-N-acetyl-glucosaminyltransferase Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)   Start Trial
Uridine-5'-Diphosphate   Start Trial Joint lubrication with P2Y purinergic receptor agonists Inspire Pharmaceuticals, Inc. (Durham, NC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Uridine-5'-Diphosphate

Drugname Country Document Number Estimated Expiration Related US Patent
Uridine-5'-Diphosphate Australia 2006251562 2025-05-23   Start Trial
Uridine-5'-Diphosphate Australia 2006251569 2025-05-23   Start Trial
Uridine-5'-Diphosphate Brazil PI0613274 2025-05-23   Start Trial
Uridine-5'-Diphosphate Brazil PI0613303 2025-05-23   Start Trial
Uridine-5'-Diphosphate Canada 2645645 2025-05-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
McKinsey
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.